摘要
肺移植供肺缺血再灌注损伤（IRI）是导致肺移植失败的主要原因之一。本文通过回顾近年来肺移植术后供肺IRI的现状，归纳其病理生理机制，总结当前较为有效的治疗措施，就该临床难题的未来进展作简要综述。
Abstract
Ischemia reperfusion injury (IRI) is one of the main causes of lung transplantation failure. In this review, we summarized the current status of IRI after lung transplantation in recent years, pathophysiological mechanisms, the current effective therapeutic measures, and the future progress of this clinical problem.
万方数据